The DOI matches its Crossref record; 217 of the 218 references it cites were found in a registry or an index.
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Open accessAbstract
Parkinson’s disease (PD) is the second most common neurodegenerative disease characterized by motor dysfunction. Growing evidence has demonstrated that gut dysbiosis is involved in the occurrence, development and progression of PD. Numerous clinical trials have identified the characteristics of the changed gut microbiota profiles, and preclinical studies in PD animal models have indicated that gut dysbiosis can influence the progression and onset of PD via increasing intestinal permeability, aggravating neuroinflammation, aggregating abnormal levels of α-synuclein fibrils, increasing oxidative stress, and decreasing neurotransmitter production. The gut microbiota can be considered promising diagnostic and therapeutic targets for PD, which can be regulated by probiotics, psychobiotics, prebiotics, synbiotics, postbiotics, fecal microbiota transplantation, diet modifications, and Chinese medicine. This review summarizes the recent studies in PD-associated gut microbiota profiles and functions, the potential roles, and mechanisms of gut microbiota in PD, and gut microbiota-targeted interventions for PD. Deciphering the underlying roles and mechanisms of the PD-associated gut microbiota will help interpret the pathogenesis of PD from new perspectives and elucidate novel therapeutic strategies for PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“gut microbial dysbiosis not only leads to intestinal inflammation but also increases intestinal permeability.”
From Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease (2023) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Tamtaji, O. R., Taghizadeh, M., Daneshvar Kakhaki, R., Kouchaki, E., Bahmani, F., Borzabadi, S., Oryan, S., Mafi, A., & Asemi, Z. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.05.018 · Cited by 398
RetractedRetracted: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease
Heinzel, S., Aho, V. T. E., Suenkel, U., von Thaler, A., Schulte, C., Deuschle, C., Paulin, L., Hantunen, S., Brockmann, K., Eschweiler, G. W., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25788 · Cited by 95
RetractedLinking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
The role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357
Dorsey, E. R., Elbaz, A., Nichols, E., Abbasi, N., Abd-Allah, F., Abdelalim, A., Adsuar, J. C., Ansha, M. G., Brayne, C., Choi, J.-Y. J., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30295-3 · Cited by 2,816
Flagged first, then by citations
1 of the 218 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–178 of 178
Glinert, A., Zlidennyy, V., Turjeman, S., Sharon, E., Schweitzer, R., Khatib, S., Izakson, L., & Koren, O. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116196 · Cited by 5
A mixed methods feasibility study of a ketogenic diet as treatment for Parkinson’s disease
Worster, K., Colgan, D. D., Vita, A. A., McClure, C., Buttolph, L., Hodges, R., Senders, A., Erlandsen, A., Elbarbry, F., & Zwickey, H. L. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1601446 · Cited by 4
The Gut Microbiota in Parkinson’s Disease: Mechanistic Insights into Microbial–Host Interactions
Guerrero-Torres, L. E., García-Galindo, J. J., Gómez-Galindo, M. F., Delgado, D. I. R., Carlos, C. E. R., Suárez-Rico, D. O., Beltrán-Ramírez, A., & Balleza-Alejandri, L. R. (2026) · Microorganisms · doi:10.3390/microorganisms14030673 · Cited by 5
Dietary supplements for Parkinson's disease: State of the science
Prasad, A., Shuler, M. G. H., Flanagan, R., Dayal, V., & Lithander, F. E. (2026) · Journal of Parkinson s Disease · doi:10.1177/1877718x261446386 · Cited by 4
The Gut-Brain Axis (GBA): Implications for Brain Longevity
Gautam, P., Vishwakarma, R. K., & Pathak, A. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2790-8_9 · Cited by 4
Mirab, F., Pirhaghi, M., Otzen, D. E., & Saboury, A. A. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167862 · Cited by 4
Bali, P., Lal, P., Sivapuram, M. S., Kutikuppala, L. V. S., Avti, P., Chanana, A., Kumar, S., & Anand, A. (2024) · Neuroepidemiology · doi:10.1159/000538416 · Cited by 4
Martín‐Bastida, A., & Rodríguez-Oroz, M. C. (2025) · Journal of Movement Disorders · doi:10.14802/jmd.24257 · Cited by 3
Stereotactic infusion of rotenone into the SN induced a late-stage model of Parkinson's disease
Liu, Y., Wang, R., Sun, F., Wang, N., Wang, M., Cai, J., Zhao, B., Zhang, Q., Ge, R., & Wang, H. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115382 · Cited by 3
Halverson, T., & Alagiakrishnan, K. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin36616 · Cited by 4
Mark, J. R., Staley, H. A., Titus, A. M., Agin‐Liebes, J., Garrido, A., Hughes, L. P., Dzamko, N. L., Wallings, R. L., & Tansey, M. G. (2025) · Movement Disorders · doi:10.1002/mds.70123 · Cited by 3
Psychobiotics at the Frontiers of Neurodegenerative and Neuropsychiatric Research
Jiménez-Pareyón, G. R., Cristóbal-Luna, J. M., García-Martínez, Y., Garfias-Noguez, C., Damián, M. R., Torres-Maravilla, E., & Sánchez-Pardo, M. E. (2025) · Microorganisms · doi:10.3390/microorganisms13122718 · Cited by 4
Therapeutic role of probiotics in motor and non-motor symptoms of Parkinson’s disease
Páez‐García, S., Hernández-Triana, D., Salazar, F. E., Barreto, G. E., Rodríguez-Oroz, M. C., & Borda, M. G. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2025.1004129 · Cited by 3
Banerjee, A., Goswami, A., & Choudhury, A. (2025) · BioNanoScience · doi:10.1007/s12668-025-02276-9 · Cited by 3
Mu, R., Liu, T., Zhang, Y., Xiu, K., Guo, X., & Xia, W. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s566113 · Cited by 3
Altan, Z. B., & Ihlamur, M. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01798-9 · Cited by 4
Chen, X., Wang, P., Luo, W., Wang, J., Sun, L., Li, Y., Zhang, F. F., & Gao, X. (2025) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2025-336045 · Cited by 3
Food for thought: probiotic modulation of microglial activity in Parkinson's disease
Kimber, I. K., & Tremblay, M. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1690507 · Cited by 4
Wang, B., Geng, L., Wang, J., Wei, Y., Yan, C., Wu, N., Yue, Y., & Zhang, Q. (2024) · Marine Drugs · doi:10.3390/md22050193 · Cited by 4
Bhardwaj, K., Singh, A. A., & Kumar, H. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00293 · Cited by 4
Microbiome Engineering towards Disease Therapy
Krishnan, A., & Dasgupta, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-6270-5_5 · Cited by 3
The gut microbiota is not linked to acute noise-induced hearing loss in C57BL/6 mice
Sato, K., Araya, K., Wu, C., Dong, E., Watson, R., Maskey, M., Nguyen, C. D., Khanipov, K., Yang, Q., & Wu, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-07669-0 · Cited by 2
Al‐Okbi, S. Y., Ramadan, A., Mohamed, R. S., Mabrok, H. B., & Al-Siedy, E. S. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-08740-6 · Cited by 2
Iyengar, A. S., Dunkley, P. R., & Dickson, P. W. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578755 · Cited by 3
Abuljadayel, D. A. (2025) · Journal of Applied Hematology · doi:10.4103/joah.joah_80_25 · Cited by 2
The Gut-Brain Axis: A Critical Link between Type 2 Diabetes and Parkinson’s disease
Almohmadi, N. H., Al‐kuraishy, H. M., Hussein, K. S., Turkistani, A., Yousef, F. M., Al-Gareeb, A. I., Abdelaziz, A. M., Elewa, Y. H. A., & Batiha, G. E. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11014-w · Cited by 2
Immunology and microbiome: Implications for motor systems
Mahjoub, Y., & Martino, D. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00001-7 · Cited by 2
Probiotic Supplementation in Parkinson’s Disease
Nisa, A. I., Amalisa, R. N., Kristantya, I., Haryono, Y., & Nugraha, P. (2024) · Surabaya Medical Journal · doi:10.59747/smjidisurabaya.v2i1.55 · Cited by 2
O papel da microbiota intestinal nos distúrbios neuropsiquiátricos e neurodegenerativos
Ferreira, V. G., & Cardoso, A. M. (2024) · Revista Brasileira Militar de Ciências · doi:10.36414/rbmc.v10i24.177 · Cited by 5
The Role of Gastrointestinal Dysbiosis and Fecal Transplantation in Various Neurocognitive Disorders
Castro-Vidal, Z. A., Mathew, F., Ibrahim, A. A., Shubhangi, F., Cherian, R., Choi, H. K., Begum, A., Ravula, H. K., & Giri, H. (2024) · Cureus · doi:10.7759/cureus.72451 · Cited by 2
Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson’s disease (PD)
Kumar, R., & Kumar, R. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.03.004 · Cited by 3
Immune perturbation by the ileal microbiota in multiple sclerosis
Jensen, L. T., & Fugger, L. H. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2506777122 · Cited by 3
Emerging Relationship Between the Gut Microbiota and Neurodegenerative Disorders
Iyer, S., Verma, S., Marathe, S. A., & Tare, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_11 · Cited by 2
Madison, C. A., Debler, R. A., Gallegos, P. L., Hillbrick, L., Chapkin, R. S., Safe, S. H., & Eitan, S. (2024) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000806 · Cited by 1
The Microbial and Metabolic Link Between Gut and Brain
Salamalek, R., Shareef, Y., Abdulridha, F., & Soliman, S. S. M. (2025) · Springer eBooks · doi:10.1007/978-981-96-1305-2_17 · Cited by 1
How gut microbes affect Parkinson’s disease: an editorial
Nasir, R., Haseeb, A., Mustafa, M. S., Mussarat, A., Ali, L., Shafique, M. A., & Ahmed, K. A. H. M. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003098 · Cited by 1
Ojukwu, E. A., Ojukwu, V. E., & Davis, J.-M. (2025) · JUNIOR RESEARCHERS · doi:10.52340/jr.2025.03.02.06 · Cited by 1
Gut microbiota in regulation of neuromuscular coordination
Roy, S., Chakraborty, B., & Choudhury, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33351-4.00024-6 · Cited by 1
Neuroprotective Attributes of Gut-derived Urolithins in Parkinson’s Disease
Chhetry, S., Roy, A., Roy, R., Bhattacharya, P., Tapias, V., & Borah, A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05541-w · Cited by 1
Exploring the skin as an open window onto neurodegenerative diseases
Lozzi, F., Camera, E., Cardinali, G., & Nardo, A. D. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00522-4 · Cited by 3
Examination of shared gut microbiome signatures in aging and Parkinson’s disease
Tng, T. J. W., Vanan, S., Tan, E.-K., Zeng, L., Goh, W. W. B., Wong, H. S., & Lim, K. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1745455 · Cited by 3
Callaghan, R. (2023) · Science Insights · doi:10.15354/si.23.re701 · Cited by 1
The Role of the Gut Microbiome in Neurological Diseases
Turner, T.-A. J., & Mangalam, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00103-2 · Cited by 3
New insights in non-motor symptoms in Parkinson’s disease
Falup‐Pecurariu, C., Fanciulli, A., Borgohain, R., Chaudhuri, К. R., & Metta, V. (2024) · Frontiers research topics · doi:10.3389/978-2-8325-4722-9 · Cited by 1
Association between gut microbiota and thyroid dysfunction
Алексеевич, Т. А., Александровна, М. О., Олеговна, Щ. А., Martirosian, N. S., Валерьевна, Г. Е., Кузина, И. А., Эдуардовна, Т. М., Valeeva, F. V., & Petunina, N. A. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-073 · Cited by 1
Update Review of the Relationship Between Gut Microbiota and Neurodegenerative Diseases
Wang, Y., Jing, G., Fu, Y., Li, Y., & Wu, C. (2024) · Diseases & Research · doi:10.54457/dr.202401007 · Cited by 1
A review of gut microbiota as a therapeutic approach for Parkinson’s disease
Ghosh, D., Ghosh, S., Sharma, M., & Datta, S. (2024) · MGM Journal of Medical Sciences · doi:10.4103/mgmj.mgmj_296_24 · Cited by 2
Borah, P., Das, P., Bordoloi, R., Deori, S., Chutia, B. C., Dutta, R., & Baruah, C. (2024) · Journal of Applied and Natural Science · doi:10.31018/jans.v16i4.5873 · Cited by 1
Zhou, L., Han, D., Zheng, T., Wang, X., & Xie, H. (2023) · Research Square · doi:10.21203/rs.3.rs-2901427/v1
Tevzadze, G., & Kikvidze, Z. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.25.586517
Sahu, A. K., Sahoo, R., Jena, L., Saluja, S. S., & Sahu, P. (2024) · Studies in computational intelligence · doi:10.1007/978-3-031-53148-4_4
Exploring the Interplay Between Gut Microflora and Parkinson’s
Swathi, M., Hazra, A., Dhanu, A. S., & Basalingappa, K. M. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_15
A Comprehensive Review of Medicinal Herbs Improving Gut-Brain Health
Ramanathan, A., Rani, K. R. V., Bhupathyraaj, M., Sridhar, S. B., Shareef, J., & Thomas, S. (2024) · Springer eBooks · doi:10.1007/978-981-19-3949-5_36-1 · Cited by 1
A Comprehensive Review of Medicinal Herbs Improving Gut-Brain Health
Ramanathan, A., Rani, K. R. V., Bhupathyraaj, M., Sridhar, S. B., Shareef, J., & Thomas, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_36
The Gut-Brain Connection: Investigating the Correlation between Autism Disorder and Gut Bacterium
Manaf, W., Dileep, N., Manaf, H., Dileep, N., & Liyakath, A. (2025) · American Journal of Medical Science and Innovation · doi:10.54536/ajmsi.v4i1.3818
Role of microbiota gut–brain axis in Parkinson's disease
Mansuri, R., Dhanawat, M., Patel, S., Garima, G., & Diwan, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21680-0.00003-1
Olalekan, S. O., Okwute, P. G., Osonuga, I. O., Mofolorunso, A. M., Adegbesan, B. O., Ezima, E. N., & Oluwatunase, G. O. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009908
Gut Microbiota in Colorectal Cancer: Fundamentals, Analytical Techniques, and Its Limitations
Anand, A., Kumari, A., Manjula, S. N., & Mruthunjaya, K. (2025) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-031-86065-2_6
«Brain—gut—microbiome» axis in patients with Parkinson’s disease
Жукова, Н. Г., Sayfitdinkhuzhaev, Z. F., Israilova, G. M., Bustonov, O. Y., Nasriddinova, N. A., Gaponova, O. V., Zhukova, I. A., & Masenko, A. Y. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202512511218
Sayfitdinkhuzhaev, Z. F., Жукова, Н. Г., Nasyrova, R. F., Gaponova, O. V., Zhukova, I. A., Masenko, A. Y., & Baydanova, A. N. (2026) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20261260117 · Cited by 2
Kumari, N., Pal, G., Chawak, K., Arbi, S. H., & Anand, S. K. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02281-2
The Brain–Gut–Microbiome Axis in Patients with Parkinson’s Disease
Жукова, Н. Г., Sayfitdinkhuzhaev, Z. F., Israilova, G. M., Bustonov, O. Y., Nasriddinova, N. A., Gaponova, O. V., Zhukova, I. A., & Masenko, A. Y. (2026) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-026-01998-x
He, R., Lu, L., & Wang, J. (2026) · Medicine · doi:10.1097/md.0000000000048488
Bhatt, M., & Desai, H. (2026) · Research Journal of Pharmacognosy and Phytochemistry · doi:10.52711/0975-4385.2026.00024
Parkinson’s Disease and the Microbiome: A New Frontier for Early Diagnosis
Chakkittukandiyil, A., & Sajini, D. V. (2026) · Springer eBooks · doi:10.1007/978-981-95-7494-0_4
The Role of Inflammation in the Brain: A Gut-Driven Phenomenon
Mahbub, N. U., Islam, M. M., & Hong, S. T. (2026) · Springer eBooks · doi:10.1007/978-981-95-7494-0_9
Gut Dysbiosis in Alzheimer’s Disease: Insights from the Microbiome
Kiran, N. S., Yashaswini, C., Chatterjee, A., & Prajapati, B. G. (2026) · Springer eBooks · doi:10.1007/978-981-95-7494-0_11
Hoedt, E. C., Duncanson, K., Simm, N. M., Williams, G. M., & Talley, N. J. (2026) · Research Square · doi:10.21203/rs.3.rs-9962008/v1
Micro- and nanoplastics as environmental modifiers of neuroimmune dysfunction in Parkinson’s disease
Qian, S., Gao, F., & Wang, P. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1886999
Sun, G., Liu, W., Tu, Y., Liu, Q. Y., & 冯美江 (2026) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2026.102564
Liang, B., Zou, J., Mao, X., Xie, N., & Zhaohui, L. (2026) · Revista de Neurología · doi:10.31083/rn50106
Sayfitdinkhuzhaev, Z. F., Жукова, Н. Г., Nasyrova, R. F., Gaponova, O. V., Zhukova, I. A., Masenko, A. Y., & Baydanova, A. N. (2026) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-026-02032-w
Fecal microbiota transplantation in Parkinson’s disease: a systematic review
Eissazade, N., Mosavari, H., Eghdami, S., Rohani, M., Fereshtehnejad, S., & Khoeini, T. (2026) · Neurodegenerative Disease Management · doi:10.1080/17582024.2026.2715585
VERMA, K., Kaur, J., Kumar, M., Awasthi, A., Kumar, D., Choudhary, N., & Abdallah, E. M. (2026) · Pharmaceuticals · doi:10.3390/ph19081311
Ultrastructural perspectives on the enteric nervous system in Parkinson’s disease
Lappe, F., Heinen‐Weiler, J., Stahlke, S., & Theiß, C. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1927448
Kumari, A., & Aran, K. R. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01978-7
Park, S., Choi, J., Sadra, A., Lee, S.-H., & Sohn, J. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1867057
Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · doi:10.20944/preprints202506.2099.v2 · Cited by 57
Metadata
- Authors
- Zhu, M., Liu, X., Ye, Y., Yan, X., Cheng, Y., Zhao, L., Chen, F., & Ling, Z.
- Affiliations
- First Affiliated Hospital Zhejiang University (CN)
- Lishui Central Hospital (CN)
- Corresponding author
- Chen, Feng
- Ling, Zongxin
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2022-06-24
- Volume
- 13
- Pages
- 937555-937555
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC9263276
- OpenAlex
- W4283465314
- Cited by
- 177
- References
- 218
- Citations by year
- 2026: 27 · 2025: 62 · 2024: 61 · 2023: 22 · 2022: 4
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (2019BINCMCF045, tsqn202103119, 31700800, JNL-2022033C, 81790631, LGF20H090016, 81771724, 2018YFC2000500, 2022C03060)
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases
- Basic Public Welfare Research Program of Zhejiang Province (81790631, 31700800, 2019BINCMCF045, JNL-2022033C, LGF20H090016, 2022C03060, tsqn202103119, 2018YFC2000500, 81771724)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Parkinson's disease, gut microbiota, gut dysbiosis, intestinal permeability, neuroinflammation, alpha-synuclein aggregation, oxidative stress, neurotransmitter production, probiotics, psychobiotics, prebiotics, synbiotics, postbiotics, fecal microbiota transplantation, diet, traditional Chinese medicine, therapeutic target
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Animals, Parkinson Disease, Neurodegenerative Diseases, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
